Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Mar 6;15(3):e35833.
doi: 10.7759/cureus.35833. eCollection 2023 Mar.

Application of a Dermal Regeneration Matrix for the Surgical Treatment of an Oromaxillary Defect in Medication-Related Osteonecrosis of the Jaw

Affiliations
Case Reports

Application of a Dermal Regeneration Matrix for the Surgical Treatment of an Oromaxillary Defect in Medication-Related Osteonecrosis of the Jaw

Rui Seixas et al. Cureus. .

Abstract

Surgical options for managing patients with medication-related osteonecrosis of the jaw are multiple and may range from superficial debridement to vascularized osteocutaneous free flaps. However, some protocols may not be an option in specific cases, and alternative techniques for patients who are not likely candidates for more invasive procedures may represent a suitable solution to treat these patients. Here, we report the case of a 69-year-old man who presented to the Stomatology Department with dysphagia, exposed bone, and mild mandibular pain for the past three months. The patient was diagnosed with stage III medication-related osteonecrosis of the jaw. Surgical debridement with sequestrum removal was performed and the remaining intraoral defect, which was unsuitable for primary closure, was addressed with a dermal regeneration matrix. This system allowed full coverage of the surgical wound. At 10 weeks of follow-up, the intraoral defect had healed completely with no need for active intervention. Dermal regeneration matrixes may represent a surgical approach to cover oromaxillary defects in select patients.

Keywords: bisphosphonates; dermal regeneration matrix; jaw osteonecrosis; mronj; oromaxillary defect.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Preoperative clinical evaluation revealing exposed bone at the lower right molar region.
Figure 2
Figure 2. On axial CT in the bone window setting, a lytic lesion with sequestrum formation (arrow) can be seen in the posterior region of the right body of the mandible.
R = right
Figure 3
Figure 3. Oromaxillary defect after debridement of necrotic bone tissue.
Figure 4
Figure 4. IDRT overlying the defect seven-day post-operation.
IDRT = Integra® Dermal Regeneration Template
Figure 5
Figure 5. Full mucosal healing at 10 weeks after IDRT removal.
IDRT = Integra® Dermal Regeneration Template

References

    1. Medication-related osteonecrosis of jaws (MRONJ) prevention and diagnosis: Italian Consensus Update 2020. Campisi G, Mauceri R, Bertoldo F, et al. Int J Environ Res Public Health. 2020;17:0. - PMC - PubMed
    1. Adjuvant therapies for MRONJ: a systematic review. Govaerts D, Piccart F, Ockerman A, Coropciuc R, Politis C, Jacobs R. Bone. 2020;141:115676. - PubMed
    1. Oral surgical management of bone and soft tissues in MRONJ treatment: a decisional tree. Marcianò A, Rubino E, Peditto M, Mauceri R, Oteri G. Life (Basel) 2020;10:0. - PMC - PubMed
    1. The basics of Integra dermal regeneration template and its expanding clinical applications. Chang DK, Louis MR, Gimenez A, Reece EM. Semin Plast Surg. 2019;33:185–189. - PMC - PubMed
    1. Use of Integra® dermal regeneration template and flowable matrix to reconstruct an oral cavity defect involving the nasal floor. Mumtaz S, Patel H, Singh M. Br J Oral Maxillofac Surg. 2020;58:0–4. - PubMed

Publication types

LinkOut - more resources